BiotechTube
Home/Zylo Therapeutics/Charles E Hinkle
CE

Charles E Hinkle

Chief Financial Officer

Zylo Therapeutics

Therapeutic Areas

DermatologySkincare/Cosmeceuticals

Zylo Therapeutics Pipeline

DrugIndicationPhase
AEA for Lupus (w/ Atticus Pharma)Lupus skin lesionsPre-clinical
Follicular Targeting ProgramAcne, AlopeciaResearch/Discovery
Solubility Enhancement ProgramUndisclosedResearch/Discovery
Y100 Mitochondrial BiogenesisSkin rejuvenation/restorationResearch/Discovery

Leadership Team at Zylo Therapeutics

SR
Scott R. Pancoast
CEO & Founder
AD
Andrew Draganski, PhD
Vice President, Product Development
CT
Clay Tucker
Research Scientist
MZ
Michael Z Rabin
Special Advisor, Strategy
View full Zylo Therapeutics profile